LONDON MARKET EARLY CALL: Stocks to fall but pound rises ahead of BoE
(Alliance News) - Stocks in London are set to open lower on Monday, with a Bank of England decision ahead, and as developments in US-China relations are also in focus.
Read moreWed, 08th Jul 2020 07:18
(Alliance News) - Stocks in London are set to open lower on Monday, with a Bank of England decision ahead, and as developments in US-China relations are also in focus.
Read more(Alliance News) - London's FTSE 100 closed higher, though equities in mainland Europe weakened, after both the Federal Reserve and European Central Bank both hinted that they are not done with rate hikes.
Read more(Alliance News) - AstraZeneca PLC on Tuesday announced another approval in China for Soliris to treat a rare neuromuscular disease.
Read moreJune 12 (Reuters) - Novartis said it has agreed to acquire U.S. biotech firm Chinook Therapeutics for up to $3.5 billion to boost its late-stage drug development line-up, raising the stakes in the race for a rare kidney disease treatment.
Read more(Alliance News) - AstraZeneca PLC on Monday said its breast cancer drug capivasertib in combination with breast-cancer treating hormone therapy drug faslodex has been granted priority review in the US for patients with advanced HR-positive breast cancer.
Read more(Sharecast News) - AstraZeneca announced on Friday that the US Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) had unanimously voted in favour of 'nirsevimab' as a preventive treatment for respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in newborns and infants.
Read more(Alliance News) - AstraZeneca PLC on Friday reported positive phase 3 trial data for its oral drug danicopan and struck an agreement with London-based biopharma company Quell Therapeutics Ltd.
Read more(Alliance News) - Stocks in London were called to open higher on Friday, after a weak US jobless claims reading threw "cold water" over expectations for an interest rate hike by the Federal Reserve next week.
Read more(Alliance News) - AstraZeneca PLC on Thursday said that a US Food & Drug Administration committee unanimously recommended its antibody nirsevimab.
Read moreIndivior jumps on U.S. Suboxone lawsuit settlement
*Read more(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday reported positive results from trials of two cancer drugs, Enhertu and datopotamab deruxtecan.
Read more(Alliance News) - AstraZeneca PLC on Monday said its Andexxa phase four trial will be stopped early after achieving positive efficacy data.
Read more(Alliance News) - AstraZeneca PLC on Friday reported positive results from planned interim analysis of a phase three trial evaluating its Imfinzi drug in gastric and gastroesophageal junction cancers.
Read more(Alliance News) - AstraZeneca PLC on Thursday hailed another approval for cancer drug Lynparza, while it ceased its development programme for Crohn's disease-focused brazikumab.
Read more